109 related articles for article (PubMed ID: 28042953)
21. Advancements in the Understanding of Small-Cell Neuroendocrine Cervical Cancer: Where We Stand and What Lies Ahead.
Wang Y; Qiu H; Lin R; Hong W; Lu J; Ling H; Sun X; Yang C
J Pers Med; 2024 Apr; 14(5):. PubMed ID: 38793044
[TBL] [Abstract][Full Text] [Related]
22. Integrated mutational landscape analysis of poorly differentiated high-grade neuroendocrine carcinoma of the uterine cervix.
Bellone S; Jeong K; Halle MK; Krakstad C; McNamara B; Greenman M; Mutlu L; Demirkiran C; Hartwich TMP; Yang-Hartwich Y; Zipponi M; Buza N; Hui P; Raspagliesi F; Lopez S; Paolini B; Milione M; Perrone E; Scambia G; Altwerger G; Ravaggi A; Bignotti E; Huang GS; Andikyan V; Clark M; Ratner E; Azodi M; Schwartz PE; Quick CM; Angioli R; Terranova C; Zaidi S; Nandi S; Alexandrov LB; Siegel ER; Choi J; Schlessinger J; Santin AD
Proc Natl Acad Sci U S A; 2024 Apr; 121(17):e2321898121. PubMed ID: 38625939
[TBL] [Abstract][Full Text] [Related]
23. Advances in Research, Diagnosis, and Treatment of Neuroendocrine Cervical Carcinoma: A Review.
Ren X; Wu W; Li Q; Li W; Wang G
Oncol Rev; 2023; 17():11764. PubMed ID: 38025893
[TBL] [Abstract][Full Text] [Related]
24. Whole exome sequencing identifies common mutational landscape of cervix and endometrium small cell neuroendocrine carcinoma.
Wang W; Zhang F; Li Y; Chen B; Gu Y; Shan Y; Li Y; Chen W; Jin Y; Pan L
Front Oncol; 2023; 13():1182029. PubMed ID: 37920164
[TBL] [Abstract][Full Text] [Related]
25. Small cell neuroendocrine carcinoma of the cervix: From molecular basis to therapeutic advances.
Chao A; Wu RC; Lin CY; Chang TC; Lai CH
Biomed J; 2023 Oct; 46(5):100633. PubMed ID: 37467967
[TBL] [Abstract][Full Text] [Related]
26. Quantitative proteomics analysis in small cell carcinoma of cervix reveals novel therapeutic targets.
Qiu H; Su N; Wang J; Yan S; Li J
Clin Proteomics; 2023 Apr; 20(1):18. PubMed ID: 37031178
[TBL] [Abstract][Full Text] [Related]
27. Mixed mucinous adenocarcinoma/large cell neuroendocrine carcinoma of the uterine cervix: case report and molecular characterization of a rare entity.
Fattorini C; Rocca BJ; Giusti A; Arganini M; Perotti B; Cavazzana A; Ambrosio MR; Volante M
Virchows Arch; 2024 Jan; 484(1):141-146. PubMed ID: 36988712
[TBL] [Abstract][Full Text] [Related]
28. Neuroendocrine Neoplasms of the Gynecologic Tract.
Virarkar M; Vulasala SS; Morani AC; Waters R; Gopireddy DR; Kumar S; Bhosale P; Lall C
Cancers (Basel); 2022 Apr; 14(7):. PubMed ID: 35406607
[TBL] [Abstract][Full Text] [Related]
29. The genomic landscape of 85 advanced neuroendocrine neoplasms reveals subtype-heterogeneity and potential therapeutic targets.
van Riet J; van de Werken HJG; Cuppen E; Eskens FALM; Tesselaar M; van Veenendaal LM; Klümpen HJ; Dercksen MW; Valk GD; Lolkema MP; Sleijfer S; Mostert B
Nat Commun; 2021 Jul; 12(1):4612. PubMed ID: 34326338
[TBL] [Abstract][Full Text] [Related]
30. Genomic analyses of high-grade neuroendocrine gynecological malignancies reveal a unique mutational landscape and therapeutic vulnerabilities.
Mahdi H; Joehlin-Price A; Elishaev E; Dowlati A; Abbas A
Mol Oncol; 2021 Dec; 15(12):3545-3558. PubMed ID: 34245124
[TBL] [Abstract][Full Text] [Related]
31. Genomic characterization of small cell carcinomas of the uterine cervix.
Schultheis AM; de Bruijn I; Selenica P; Macedo GS; da Silva EM; Piscuoglio S; Jungbluth AA; Park KJ; Klimstra DS; Wardelmann E; Hartmann W; Gerharz CD; von Petersdorff M; Buettner R; Reis-Filho JS; Weigelt B
Mol Oncol; 2022 Feb; 16(4):833-845. PubMed ID: 33830625
[TBL] [Abstract][Full Text] [Related]
32. Histology-specific
Gill CM; Orfanelli T; Yoxtheimer L; Roy-McMahon C; Suhner J; Tomita S; Kalir T; Liu Y; Houldsworth J; Kolev V
Gynecol Oncol Rep; 2020 Nov; 34():100668. PubMed ID: 33241100
[TBL] [Abstract][Full Text] [Related]
33. Comparative genomics of high grade neuroendocrine carcinoma of the cervix.
Hillman RT; Cardnell R; Fujimoto J; Lee WC; Zhang J; Byers LA; Ramalingam P; Leitao M; Swisher E; Futreal PA; Frumovitz M
PLoS One; 2020; 15(6):e0234505. PubMed ID: 32544169
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA‑126‑3p suppresses HeLa cell proliferation, migration and invasion, and increases apoptosis via the PI3K/PDK1/AKT pathway.
Ichikawa R; Kawasaki R; Iwata A; Otani S; Nishio E; Nomura H; Fujii T
Oncol Rep; 2020 Apr; 43(4):1300-1308. PubMed ID: 32323808
[TBL] [Abstract][Full Text] [Related]
35. Pan-cancer Convergence to a Small-Cell Neuroendocrine Phenotype that Shares Susceptibilities with Hematological Malignancies.
Balanis NG; Sheu KM; Esedebe FN; Patel SJ; Smith BA; Park JW; Alhani S; Gomperts BN; Huang J; Witte ON; Graeber TG
Cancer Cell; 2019 Jul; 36(1):17-34.e7. PubMed ID: 31287989
[TBL] [Abstract][Full Text] [Related]
36. Neuroendocrine carcinoma of the cervix: a systematic review of the literature.
Tempfer CB; Tischoff I; Dogan A; Hilal Z; Schultheis B; Kern P; Rezniczek GA
BMC Cancer; 2018 May; 18(1):530. PubMed ID: 29728073
[TBL] [Abstract][Full Text] [Related]
37. A gastric MANEC with an adenocarcinoma of fundic-gland type as exocrine component.
Nassereddine H; Poté N; Théou-Anton N; Lamoureux G; Fléjou JF; Couvelard A
Virchows Arch; 2017 Nov; 471(5):673-678. PubMed ID: 28653202
[No Abstract] [Full Text] [Related]
38. Cervical small cell neuroendocrine tumor mutation profiles via whole exome sequencing.
Cho SY; Choi M; Ban HJ; Lee CH; Park S; Kim H; Kim YS; Lee YS; Lee JY
Oncotarget; 2017 Jan; 8(5):8095-8104. PubMed ID: 28042953
[TBL] [Abstract][Full Text] [Related]
39. Next-generation Sequencing Reveals Recurrent Somatic Mutations in Small Cell Neuroendocrine Carcinoma of the Uterine Cervix.
Xing D; Zheng G; Schoolmeester JK; Li Z; Pallavajjala A; Haley L; Conner MG; Vang R; Hung CF; Wu TC; Ronnett BM
Am J Surg Pathol; 2018 Jun; 42(6):750-760. PubMed ID: 29505425
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
